One-year clinical outcomes of patients with versus without acute coronary syndrome with 3-month duration of dual antiplatelet therapy after everolimus-eluting stent implantation.
Natsuaki M, Morimoto T, Yamamoto E, Watanabe H, Furukawa Y, Abe M, Nakao K, Ishikawa T, Kawai K, Yunoki K, Shimizu S, Akao M, Miki S, Yamamoto M, Okada H, Hoshino K, Kadota K, Morino Y, Hanaoka KI, Tanabe K, Kozuma K, Kimura T; STOPDAPT trial investigators.
Natsuaki M, et al.
PLoS One. 2020 Mar 25;15(3):e0227612. doi: 10.1371/journal.pone.0227612. eCollection 2020.
PLoS One. 2020.
PMID: 32210433
Free PMC article.
Clinical Trial.